High thioredoxin-1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody Tregalizumab.

Heim, Katharina; Dälken, Benjamin; Faust, Stefanie; Rharbaoui, Faiza; Engling, Andre; Wallmeier, Holger; Dingermann, Theodor; Radeke, Heinfried H; Schüttrumpf, Jörg; Gutscher, Marcus

Heim, Katharina; Dälken, Benjamin; Faust, Stefanie; Rharbaoui, Faiza; Engling, Andre; Wallmeier, Holger; Dingermann, Theodor; Radeke, Heinfried H; Schüttrumpf, Jörg; Gutscher, Marcus.

Afiliação

Heim K; Biotest AG , Dreieich, Germany.
Dälken B; Biotest AG , Dreieich, Germany.
Faust S; Biotest AG , Dreieich, Germany.
Rharbaoui F; Biotest AG , Dreieich, Germany.
Engling A; Biotest AG , Dreieich, Germany.
Wallmeier H; Condor Scientific Computing and Consulting , Sulzbach, Germany.
Dingermann T; Institute of Pharmaceutical Biology, Goethe University Frankfurt , Frankfurt, Germany.
Radeke HH; Institute of Pharmacology and Toxicology/ZAFES, Clinic of the Goethe University , Frankfurt, Germany.
Schüttrumpf J; Biotest AG , Dreieich, Germany.
Gutscher M; Biotest AG , Dreieich, Germany.

Clin Transl Immunology ; 5(12): e121, 2016 Dec.

Article em En | MEDLINE | ID: mdl-28090323

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Transl Immunology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google